Which painkiller combo works best for cancer surgery? new trial aims to find out
NCT ID NCT06731998
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study compares three routine pain control methods used during minimally invasive cancer surgery: a nerve block plus local anesthetic, nerve block alone, or local anesthetic alone. About 48 adults having surgery for various cancers will be randomly assigned to one of the three groups. Researchers will track pain scores, opioid use, and side effects for the first 24 hours after surgery to see which method works best.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ropivacaine (local anesthetic)
- What this could lead to
- If successful, this could identify the best pain management approach for cancer surgery, potentially reducing opioid use and improving recovery.
- What could go wrong
- This is a small, early-stage trial with only 48 participants, so results may not apply to all patients. The differences between groups might be small.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AHN West Penn Hospital
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Could sitting up make radiation therapy more comfortable?
- Can we predict chemo brain before it happens?
- Can we predict dangerous side effects when combining radiation and immunotherapy?